Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05887973 · ClinicalTrials.gov registry record

Addressing Root Causes for Gun Violence Prevention (ARC-GVP)

A clinical trial of Aggression and Violence, sponsored by University of Michigan.

Recruiting
Registry status
250
Enrollment target
1
Study location

NCT05887973 is a study of Aggression and Violence that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 250 participants, above the 143-participant average among 21 other Aggression trials with a reported enrollment target (75% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05887973, a study of Aggression and Violence, is actively recruiting participants, sponsored by University of Michigan.

RECRUITING
Registry status
250 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to help build the evidence base for a locally-relevant youth firearm violence prevention program in Washington D.C., a city experiencing disparities in youth firearm violence outcomes. The main question it aims to answer is: How is youth participation in the summer youth employment program, the True Reasons I Grabbed the Gun Evolved from Risk (The T.R.I.G.G.E.R Project), which is designed to address root causes of gun violence, associated with individual youth behavioral outcomes, including pro-social involvement, aggression, and firearm-related attitudes and behaviors?

Interventions

  • BEHAVIORAL The T.R.I.G.G.E.R Project

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2022-06-27
Est. Completion 2026-07

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT05887973

The ClinicalTrials.gov registry entry for NCT05887973 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 143-participant average among 21 other Aggression trials with a reported enrollment target (75% higher). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Aggression appearing as the primary indexed condition, and to 1 intervention - of which The T.R.I.G.G.E.R Project is the first listed.

NCT05887973 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT05887973 about?

NCT05887973 is a clinical study titled "Addressing Root Causes for Gun Violence Prevention (ARC-GVP)". The goal of this study is to help build the evidence base for a locally-relevant youth firearm violence prevention program in Washington D.C., a city experiencing disparities in youth firearm violence outcomes. The main question it aims to answer is: How is youth participation in the summer youth ...

What is the current status of trial NCT05887973?

This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2022-06-27. Estimated completion is 2026-07.

What conditions does trial NCT05887973 study?

This clinical trial studies the following conditions: Aggression, Violence, Adolescent, Firearm Injury.

What interventions are being tested in trial NCT05887973?

The interventions under investigation include: The T.R.I.G.G.E.R Project (BEHAVIORAL).

Who is sponsoring clinical trial NCT05887973?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05887973 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aggression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.